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Abstract
There has been extensive research in the recent past looking into the molecular basis and
mechanisms of the biological clock, situated in the suprachiasmatic nuclei (SCN) of the anterior
hypothalamus. Neurotransmitters are a very important component of SCN function. Thorough
knowledge of neurotransmitters is not only essential for the understanding of the clock but also
for the successful manipulation of the clock with experimental chemicals and therapeutical drugs.
This article reviews the current knowledge about neurotransmitters in the SCN, including
neurotransmitters that have been identified only recently. An attempt was made to describe the
neurotransmitters and hormonal/diffusible signals of the SCN efference, which are necessary for
the master clock to exert its overt function. The expression of robust circadian rhythms depends
on the integrity of the biological clock and on the integration of thousands of individual cellular
clocks found in the clock. Neurotransmitters are required at all levels, at the input, in the clock
itself, and in its efferent output for the normal function of the clock. The relationship between
neurotransmitter function and gene expression is also discussed because clock gene transcription
forms the molecular basis of the clock and its working.
Introduction
Great advances have been made in the study of mecha-
nisms of the circadian clock in the past decade. Since the
identification of a master circadian clock in the suprachi-
asmatic nuclei (SCN) of the anterior hypothalamus of
mammals, researchers sought to identify the nature of the
clock and characterize its components. The SCN, acting as
circadian pacemakers, have the function of orchestrating
the timing in physiology and behaviour. They control cir-
cadian rhythms in other parts of the brain, such as the cer-
ebral cortex, in the pineal gland, and in peripheral tissues
such as liver, kidney and heart [1]. The circadian clock not
only can generate its own rhythms but can also be
entrained by the environmental light-dark (LD) cycle.
Multiple single cell circadian oscillators that are present in
the clock can, when synchronized, generate coordinated
circadian outputs which ultimately regulate the overt
rhythms.
Studies pertaining to the molecular mechanisms of the
clock have yielded valuable results with the identification
of a protein responsible for the setting of the length of
periods of activity and inactivity within cells. Many years
of research by a dedicated team of scientists culminated in
the discovery of this protein [2]. It is believed that the
identification of this protein will have far reaching impli-
cations not only in the understanding of the working of
the clock but also in clinical applications, such as the
treatment of jet lag and the design of optimal times for the
administration of anti-cancer drugs.
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The master clock, as it is often called, is reset by light or
photic stimuli [3] as well as by arousal-inducing or non-
photic stimuli [4]. Whether the input is photic or non-
photic, it reaches the clock through neurotransmitters in
nerve terminals. Neurotransmitters are released at the
inputs for entrainment, in the clock itself for integration
and consolidated output, and in efferent projections for
the control of overt rhythms. Several reviews on the neu-
rotransmitters of the SCN have been previously published
[5-10]. The present review concentrates on studies con-
ducted in the last decade and gives particular attention to
neurotransmitters whose involvement in the circadian
clock have not been traditionally recognized.
About neurotransmitters in general
Studies have indicated the presence of a large number of
neurotransmitters in the SCN [11-15]. However, informa-
tion about their role individually as well as in combina-
tion in the functioning of the clock has been slow to
come. It is observed that the presence of neurotransmit-
ters in the afferent and efferent projections of the SCN is
equally important for the entrainment of the clock and for
the control of overt rhythms. Thus, we have neurotrans-
mitters released at the inputs for entrainment, in the clock
itself for the integration and consolidated output, and in
the efferent projections for the control of overt rhythms.
There have been attempts to categorize the putative neu-
rotransmitters of the SCN on the basis of their origin and
function [16] and there have been reports indicating sub-
divisions of the SCN with relation to neurotransmitter
function [17]. Further, it has been reported [18] that the
human SCN also have well defined subdivisions with
chemically defined neuronal groups comparable to the
well defined subdivisions reported in the case of experi-
mental animals, mainly rodents. There are many excellent
reviews [19-22] highlighting various aspects of the neuro-
transmitters. From a functional point of view, two impor-
tant aspects emerge. One is the fact that one particular
neurotransmitter may have more than one function and
thereby make the prediction of the function more difficult
and complex. Another aspect is that the neurotransmitter
input from various pathways and their influence may vary
(1) by itself and (2) by way of modification of SCN func-
tion. Neurotransmitters like acetylcholine, glutamate,
neuropeptide Y (NPY), serotonin, vasoactive intestinal
peptide (VIP), peptide histidine isoleucine (PHI), and
arginine vasopressin (AVP) have been implicated in the
functioning of the SCN. Glutamate and pituitary ade-
nylate cyclase-activating polypeptide (PACAP) are indi-
cated as principal neurotransmitters of the
retinohypothalamic tract (RHT), although excitatory
amino acids like L-aspartate and N-acetyl-aspartylgluta-
mate may also function as neurotransmitters in RHT. Sub-
stance P also might be a candidate as a neurotransmitter
in RHT. Functional studies over the years have given evi-
dence that PACAP alone or in concert with glutamate may
be responsible for the light signalling to the clock.
The role of AVP in circadian time keeping has been well
established. Its role in the control of circadian rhythm of
food and water intake has been reported and well docu-
mented. Another intrinsic neuropeptide, VIP, acting
through VPAC2 receptor (a type of receptor for VIP), par-
ticipates in both resetting to light and maintenance of
ongoing rhythmicity of the SCN. NPY and GABA seem to
be the neurotransmitters in the projection from the inter-
geniculate leaflet to the SCN. Raphe nuclei projections to
the SCN contain serotonin. AVP and prokineticin 2 are
seen in the outputs from the SCN.
The neurotransmitter-dependent molecular basis of the
working of the clock is yet to be understood completely.
The specific roles of the various neurotransmitters may be
based on the response of the neurons of the SCN on appli-
cation of a neurotransmitter, capacity to phase shift a par-
ticular rhythm on application of neurotransmitter, effect
of lesions on the entrained and free running rhythms, and
disruptions seen in the rhythms after blockade by the
antagonist/inhibitors. Possible targets for some of the
neurotransmitters are the clock genes per1 and per2, which
are induced in the SCN by light or by neurotransmitters,
at night.
Evidence indicating co-localization of some of the neuro-
transmitters in the SCN has further complicated the inves-
tigations into the role of neurotransmitters in the working
of the clock. It is likely that the functioning of the clock
may depend on the presence of a particular neurotrans-
mitter on a mechanism in which co-localized neurotrans-
mitters interact in a functionally significant manner.
With more information available on the role of neuro-
transmitters in the working of the clock, which is involved
in so many functions of the body, better opportunity for
neurotransmitter-based manipulation of the clock has
also been reported. Problems of shift-work insomnia and
ill effects of jet lag are among the clock-related functions
for which much attention has been given in recent years.
Melatonin has been in use with some success in reducing
the above effects. However, search for other chronobiotic
agents is continuing and it is likely that there may be some
new dimensions given to the problem and its solution in
future. A report of a close relationship between circadian
clock and cell proliferation makes things even more inter-
esting. Investigations into the role of neurotransmitters in
the SCN as well as in the afferent and efferent inputs have
come a long way with the advent of newer techniques of
positron emission transaxial tomography (PET) scan and
polymerase chain reaction (PCR).Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
Page 3 of 20
(page number not for citation purposes)
In both plants and animals, circannual rhythms are
widely distributed. Endogenous circannual rhythms form
the basis for many seasonal rhythms. A number of neu-
roendocrine mechanisms have been implicated in the reg-
ulation of seasonal changes in the physiology and
behaviour of animals. Some of these neuroendocrine
pathways are necessary for the regulation of particular
overt seasonal responses, though they may not be directly
linked to the circadian time-keeping system. Photoperi-
odic input and circannual function may have profound
influence on many of the functions of body. Naturally,
neurotransmitters are involved not only in circadian func-
tion but also in seasonal processes. It has been postulated
that heterogeneity of the clocks which are seen within the
SCN may be one of the factors that form the basis of sea-
sonal adaptations [23]. A typical example of the close
linkage between seasonal rhythms and affective disorders
can be seen in a seasonal form of mood disorder, seasonal
affective disorder (SAD). Treatment for SAD based on cir-
cadian principles includes not only light therapy but also
the use of certain drugs, again based on circadian princi-
ples involving neurotransmitters.
The SCN has been subdivided into a dorsomedial shell
and a ventrolateral core. This is based on retinal innerva-
tion patterns as well as the observation that these regions
are defined by phenotypically distinct cell types [24]. Each
nucleus contains about 10,000 neurons, thereby making
20,000 neurons in total. These neurons are characterized
by small size and high density [25]. Isolated individual
neurons are reported to produce circadian oscillations
with periods ranging from 20–28 h [26,27]. Circadian
oscillations are generated in the individual neurons of the
SCN by a molecular regulatory network. Though individ-
ual cells oscillate with periods ranging from 20–28 h, at
the tissue level SCN neurons display synchrony indicative
of a robust inter-cellular coupling, and neurotransmitters
appear to have an important role in the inter-cellular cou-
pling. Gondze and co-workers [28] have introduced a
molecular model for the regulatory network underlying
the circadian oscillators in the SCN and stated that effec-
tive synchronization is achieved when the average neuro-
transmitter concentration damps the individual
oscillators. Cells are effectively synchronized due to global
neurotransmitter oscillation. Neither spiking in the neu-
rons of the SCN nor chemically mediated transmission is
needed for the pacemaking activity seen in individual
cells. However, synchronization of circadian rhythmicity
across neurons in the SCN does require neurotransmitters
[25,29] and development of action potentials [30].
Before attempting a discussion of the neurotransmitters, it
is necessary to identify the afferent projections to the SCN,
and neurotransmitters present in it, neurotransmitters
intrinsic to the SCN, and efferent projection with its neu-
rotransmitters. The SCN is composed of different neuro-
nal elements, each having its own specific function.
Intensive interconnection and interaction among the het-
erogeneous neuronal elements is responsible for the func-
tional output of the SCN. Different neurons of the SCN
contain different neuropeptides, with several neurons
having co-localization of neurotransmitters. Thus, we
have, for example, gamma amino butyric acid (GABA)
and glutamate, GABA and AVP, AVP and corticotrophin
releasing hormone (CRH), AVP and its carrier protein
neurophysin, VIP and peptide histidine isoleucine (PHI),
and VIP and somatostatin (SS). Co-localization of differ-
ent neuropeptides is seen not only in rat SCN but also in
human SCN [31-33]. The combination of a variety of pep-
tides with or without amino acid neurotransmitters
within a single nucleus gives the SCN a variety of signal-
ling properties as well. A set of SCN neurons and their
neurotransmitters has the function of conveying the daily
light-dark signal to hypothalamic target structures [34-
36].
Three major incoming pathways have been identified for
the SCN. These have been defined as the retinohypotha-
lamic tract (RHT), geniculohypothalamic tract (GHT),
and the projection from the raphe nuclei (Figure 1).
Photic information is relayed directly from the retina to
the SCN by way of the monosynaptic retinohypothalamic
tract [37,38]. It is seen that transection of all visual path-
ways leaving the optic chiasm makes animals blind with
no visual reflexes but with perfect normal entrainment of
circadian rhythms. This has indicated that RHT is suffi-
Afferent inputs and efferent pathways of the SCN Figure 1
Afferent inputs and efferent pathways of the SCN. 
RHT: Retinohypothalamic tract, GHT: Geniculohypothalamic 
tract, OC: Optic chiasm, 3V: Third ventricle, IGL: Intergenic-
ulate leaflet, DM: Dorsomedial SCN, VL: Ventrolateral SCN, 
NPY: Neuropeptide Y, GABA: Gamma amino butyric acid, 
PACAP: Pituitary adenylate cyclase-activating polypeptide.Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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cient for entrainment. Also it has been demonstrated that
sectioning of RHT abolishes entrainment without affect-
ing visual functions [39]. Although the exact mechanism
by which a monophasic stimulus, light, produces either
no response or a biphasic response in SCN neurons is
unclear at present, Myers and co-workers [40] provided a
potential molecular explanation for the phenomenon.
Using electron microscopy and immunohistochemistry,
they identified the excitatory amino acid glutamate and
pituitary adenylate cyclase-activating polypeptide
(PACAP) as the main neurotransmitters of the RHT [41-
43]. Although substance P (SP) was thought of as a neuro-
transmitter of the RHT, there is now substantial evidence
against this possibility [44-46].
Retinohypothalamic tract (RHT) and its 
neurotransmitters
The principal neurotransmitters involved in conveying
photic information to the SCN have been identified as
glutamate and PACAP. Light stimulation of the retina
results in direct secretion of glutamate from the RHT into
the ventral VIP-containing part of the SCN [47-49]. Gluta-
mate as a transmitter at RHT/SCN synaptic connections
plays an important and critical role in mediating photic
regulation of circadian rhythmicity. RHT terminals inner-
vating the SCN show glutamate immunoreactivity associ-
ated with synaptic vesicles [41,50], which confirms the
role of glutamate as a neurotransmitter. Different types of
glutamate receptors were identified and localized in the
SCN using in situ hybridization and immunocytochemis-
try [51]. PACAP, which is co-localized in a subpopulation
of glutamate-containing retinal ganglion cells and also
involved in relaying light information, may potentiate the
action of glutamate on the SCN [52,53]. Both glutamate
and PACAP fulfil the criteria of being located in the RHT,
being released on stimulation, affecting the cells of the
SCN in a manner similar to light, and having their effects
blocked by specific antagonists [20]. Exogenous applica-
tion of glutamate receptor (GluR) agonists is found to
excite SCN neurons [54,55] and cause phase shifts. On the
other hand, GluR antagonists block light-induced phase
shifts and Fos-induction in the SCN in vivo [56,57].
Nitric oxide (NO)
NO appears to be a crucial neuroactive substance for the
function of the SCN. Presence of neurons showing nitric
oxide synthase (nNOS) immunoreactivity in the SCN of
dwarf hamster and rat [58,59] were further confirmed by
the studies of Chen and co-workers [60] and Caillol and
co-workers [61]. Nitric oxide production in the SCN has
been linked to N-methyl D-aspartate (NMDA)-induced
cyclic guanosine monophospahate (cGMP) production,
and administration of cGMP produces phase shifts of cir-
cadian rhythms in vitro [62]. It has also been reported that
NOS inhibitors prevent NMDA-induced phase shifts of
circadian rhythms in vitro and in vivo [48]. There is also a
possibility for an additional source of NO in the SCN
from the astrocytes, as a group of cells positive for
endothelial NOS (eNOS) was found in rat and hamster
[61].
In terms of the functional impact of NO in the working of
the SCN, blocking of NO production disrupts light trans-
mission to the SCN [63], thus indicating the possibility of
the role of NO in the light-input pathway. NO synthesis is
required for phase changes of electrical activity [64].
Intracerebroventricular application of L-NAME (a drug
that blocks NOS in hamsters) produces attenuation of
light-induced phase-advances of activity rhythms [65].
Reports also indicate interruption in the light-triggered
cascade of glutamate release from retinal terminals in the
SCN by blockade of NO action in intact animals, which
leads to subsequent interruption of NMDA receptor acti-
vation [66,67]. Interruption of intracellular increase of
calcium, activation of nNOS, augmented production of
cyclic guanosine monophosphate (cGMP), activation of
protein kinase C, and phosphorylation of cyclic adenos-
ine monophosphate (cAMP) response element binding
protein (CREB), as well as interruption of the expression
of immediate early genes, are other effects of blockade of
NO action.
Starkey and co-workers [68] provided evidence for the
presence of functional type II NOS within the SCN of
guinea pig. All isotypes of NO synthase have also been
identified in the normal adult mammalian SCN. Contri-
bution by more than one NOS isotype to the regulation of
circadian rhythms cannot be ruled out. In this context, it
is interesting to note the demonstration by Kriegfeld and
co-workers [69] that mice lacking the gene for type I NOS
experience no change in the ability to phase-shift or
entrain circadian rhythm of locomotor activity. Yet
another study, also by Kreigfeld and co-workers [70], has
suggested that endothelial isoform of NOS among the
three known isoforms may not be necessary for photic
entrainment in mice. However, considering the three dif-
ferent forms of NOS identified, until the isoforms of NOS
involved in regulating the clock phase by modulating
inputs are completely established it is difficult to specu-
late the exact role of NO.
There has been much speculation as to the photopigment
mediating light information to the SCN. However, this is
not yet known with certainty [71]. A novel opsin, melan-
opsin, was identified [72] and found to be exclusively
expressed in the ganglion cells of RHT [20,73,74]. Melan-
opsin-containing RHT ganglion cells also use PACAP,
another well known neurotransmitter of the RHT [20].
Melanopsin, however may not be the only circadian pho-
toreceptor since melanopsin knock-out mice showed typ-Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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ical, although reduced, light responses such as
entrainment and phase shifting.
Possibilities of other neuroactive substances serving as
neurotransmitters in the RHT in addition to glutamate
and PACAP, which are the most important candidates,
have been indicated. Projections of substance P (SP)-con-
taining ganglion cells to the ventrolateral part of the SCN
have been demonstrated in lesion experiments in the rat
[75]. Electrophysiological investigations also further sup-
port the role of substance P as an excitatory neuromodu-
lator [76] responsible for the expression of both NMDA
and non-NMDA receptor-mediated components of RHT
transmission. Moreover, it is also reported that SP and
glutamate work as agonists upstream of glutamate [77].
Histamine
Despite substantial evidence [17,78,79] suggesting a role
for histamine as a neurotransmitter in circadian entrain-
ment [17,78,79], its role has been underplayed. With
more information available and even a suggestion that
histamine may be acting as a final neurotransmitter on
which photic and non-photic entrainment converge [80],
there has been more attention in this direction. Histamine
can induce phase shifts in circadian rhythms in a manner
similar to that of light pulses. Intracerebroventricular
injection of histamine is also found to alter circadian
function [81]. Direct effects of histamine on SCN neurons
have been shown in vitro either as inhibitory or excitatory
depending on experimental conditions [82,83]. It is also
reported that at the level of the SCN the direct excitatory
effects of histamine on neuronal firing is mediated via H1
receptors and the inhibitory effects via H2  receptors
[82,83]. However, in vivo studies, it has been shown that
the effects of histamine on circadian rhythms may be
mediated through receptors other than histamine recep-
tors [84,85]. The foregoing discussion supports the view
that histamine may exert modifying effects on circadian
rhythmicity as well as neuronal excitability. There is a
clear circadian rhythm in the histaminergic activity, with
high levels during the active period and low levels during
the sleep period. Maintenance of circadian rhythmicity of
sleep-wakefulness cycles, food intake, motility and adren-
ocortical hormone release seems to depend on histamin-
ergic activity. Thus, although evidence is accumulating for
a role of histamine in circadian function, it is difficult to
assign it a specific role in circadian activity at this time.
Neurotensin (NT)
Cell bodies of the rat SCN contain the neuropeptide neu-
rotensin (NT) and two NT receptor types, namely NTS1
and NTS 2 [86-88]. In humans there is a larger population
of NT neurons as compared to monkeys and other ani-
mals. Although involved in many physiological processes,
the role of NT in circadian rhythm is not completely
known at present. Meyer-Spasche and co-workers [89]
reported that NT can phase shift the firing rate rhythm of
SCN neurons. They also provided evidence that NT may
play a role in regulating the circadian pacemaker through
NTS1 and NTS2 receptors. NT-binding sites found in the
ventral region of the SCN, which receives photic and non-
photic information, is indicative of the involvement of NT
in the synchronization of clock to these environmental
stimuli [90]. Studies using NTS1 and NTS2 agonists, neu-
rotransmitter receptor antagonists, as well as the exoge-
nous application of NT, have yielded some valuable
results. An increase in discharge rate of SCN neurons was
observed on NT application [90]. NT-mediated effects on
SCN neurons seem to result from activation of NTS1 and
NTS2 receptors rather than involve glutamate or GABA
receptors or modulation of the synaptic release of gluta-
mate or GABA [90]. NPY, which is an established neuro-
transmitter of the geniculohypothalamic tract (GHT), was
found to regulate SCN neuronal activity [91-93] and to
produce long lasting suppression of firing rate of SCN
neurons. When co-applied with NPY, NT was found to
damp the profound inhibitory effect of NPY [90,92,93].
This is interesting since there are studies showing that
NPY immunoreactive terminals overlap with NT-binding
sites in the ventral part of the SCN. This was considered as
evidence of an interaction of NPY and NT to regulate neu-
ral activity. From a developmental point of view, NT-
expressing neurons developed earlier than the other 3
types of peptidergic neurons, NPY, VIP and AVP [94]. It
remains to be seen whether NT-expressing neurons con-
tribute significantly to the generation of circadian
rhythms in early human life.
Neuromedin S (NMS)
A recent addition to the ever increasing list of neurotrans-
mitters of the SCN is neuromedin S (NMS), a 36 amino
acid neuropeptide. It is a potent brain-gut neuropeptide
whose presence in the SCN was reported by Nakahara and
co-workers [95] as a neurotransmitter of the circadian
oscillator system. NMS expression is found to be restricted
to the core part of the SCN and has a diurnal peak under
light-dark cycle [96]. Intracerebroventricular administra-
tion of neuromedin S in rats activates SCN neurons and
has the capability to induce non-photic type of phase
shifts in the circadian rhythm of locomotor activity. It is
also possible that NMS along with VIP may have a role in
maintenance of circadian rhythmicity. Recently, it has
been shown that neuromedin M (NMU) is regulated in a
circadian manner with peak expression in the light phase
of LD cycle [97]. Further studies are required to under-
stand the specific role of NMS in the SCN. At present, it is
implicated in the regulation of circadian rhythms through
autocrine and /or paracrine actions through its receptors
[96].Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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Gastrin releasing peptide (GRP)
Gastrin releasing peptide (GRP) has also been identified
as a neurotransmitter in the SCN. Although GRP and its
receptor BB2 are found to be synthesized by rodent SCN
neurons [98-100], the role of GRP in circadian rhythm
regulation is not well known. Evidence points towards a
role for GRP in photic entrainment [101,102], in spite of
a number of studies favouring glutamate as the main neu-
rotransmitter [36,37,103]. McArthur and co-workers
[104] studied the role of GRP in photic entrainment by
using the resetting actions of GRP application on electrical
activity rhythms during subjective day, early subjective
night, and late subjective night in vitro in rats and ham-
sters. Their studies have shown phase delay on SCN neu-
ron firing during early subjective night and phase advance
during late subjective night with no response on applica-
tion during subjective day. Phase shifts were blocked by a
BB2 receptor antagonist, thereby confirming the role of
GRP in the participation of photic entrainment. GRP
found within calbindin-containing retinorecipient cells
and also causing photic-like phase shifts on application
directly to the SCN may be a possible neurotransmitter for
intra-SCN communication [105].
Acetylcholine (ACh)
Acetylcholine (ACh) has the distinction of being identi-
fied as the first neurotransmitter for the regulation of cir-
cadian rhythms. There is evidence in favour and against
acetylcholine as a neurotransmitter in the literature. It was
suggested that acetylcholine plays a role in the light-input
pathway on the basis of some of the studies [16,106].
Electrophysiological studies indicating excitation of some
neurons of the SCN by cholinergic agents [107,108] have
supported the role of acetylcholine. Use of the acetylcho-
line receptor agonist carbachol, a non-specific agonist, to
mimic the effects of light [109] also added to the support-
ing evidence for the role of acetylcholine in the SCN. The
effect is mediated by muscarinic receptors of the M1 sub-
type [110]. Intraventricular administration of carbachol,
which caused phase shifts in vivo, could be blocked by
GluR antagonists [111]. However, acetylcholine does not
appear to be directly involved as a neurotransmitter in the
light-input pathway. It may act to modulate the photic
information reaching the SCN.
Geniculohypothalamic tract
The geniculohypothalamic tract (GHT) is a second affer-
ent photic projection from the intergeniculate leaflet
(IGL) to the SCN. The IGL receives input directly from the
retina via a separate branch of the RHT. The projection
from IGL via GHT terminates in the areas of the SCN that
overlap the direct RHT-SCN input. GHT provides a sec-
ondary, indirect photic input as well as an alternate input
which has an important role in entrainment mediated by
non-photic stimuli such as motor activity. While lesions
of the IGL block activity induced phase shifts [112], elec-
trical stimulation produces phase shifts similar to those
produced by activity [113]. It has been reported that IGL
mediates photoperiodic responses as well as non-photic
entrainment of circadian rhythms [114,115]. Hence, the
IGL may have integration of photic and non-photic infor-
mation as its function. In addition to neuropeptide Y
(NPY), GHT may also have GABA and enkephalin (ENK)
as neurotransmitters in rat and hamster [116,117]. ENK
was found in cell bodies in the IGL as well as in fibres in
the SCN of many mammalian species. High density of
delta opioid receptors, which have the highest affinity for
ENK, was detected in the hamster SCN [118] and an ENK
agonist phase-advanced hamster wheel running activity
late in subjective day [119].
Neuropeptide Y (NPY)
RHT and GHT exhibit partial overlapping in the SCN. The
SCN exhibits immunoreactivity for NPY [120]. There is
evidence that IGL mediates both photoperiodic and non-
photic entrainment of circadian rhythms [114]. NPY, the
primary transmitter of GHT, acts directly on pacemaker
neurons of the SCN in hamsters [121]. IGL neuron projec-
tions to the SCN also have GABA/NPY immunoreactivity
and those projecting to contralateral IGL have GABA/ENK
immunoreactivity [116,122]. There may be co-localiza-
tion of NPY and GABA in the GHT projections. Since
many features of the response to light by the circadian sys-
tem remain unaffected by IGL lesion in animals, it is sug-
gested that this pathway may not be critical for the photic
regulation.
Further evidence is available to emphasize the importance
of GHT to cause non-photic phase shifts during the day
but not during the night, such as the phase-shifts evoked
by activity induced by novel stimuli [123,124]. The phase
shifts are abolished by IGL lesions. Both in vitro and in
vivo NPY administration produced a similar pattern of
phase shifts during the day, which was blocked by bicuc-
ulline [125]. NPY has also been found to act presynapti-
cally to inhibit GABA-mediated synaptic transmission
through inhibition of calcium currents [126].
Serotonin (5HT)
A dense, robust serotonergic projection from midbrain
raphe nuclei terminating predominantly in the retinore-
cipient region of the SCN has been reported [127]. A
reciprocal projection from the SCN to raphe nuclei is also
seen [128]. Both in vitro and in vivo, 5HT receptor ago-
nists are found to cause phase shifts of the SCN when
administered at times in the circadian cycle during which
light does not cause phase shifts [129,130]. Raphe nuclei
lesions reduce the amplitudes or "clarity " of rat's circa-
dian activity rhythm [131] with detectable persistent
rhythmicity. Serotonergic projection to the SCN terminateJournal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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to a great extent on vasoactive intestinal peptide(VIP)-
containing neurons in the ventrolateral part of the SCN.
There is a close relation between retinal afferents and VIP-
containing neurons of the SCN in this area [132].
The major function of the serotonergic projection most
probably is the modulation of the pacemaker responses to
light. Raphe nuclei receive retinal afferents [133] and
hence the raphe-retina projection may be viewed as
another indirect photic input to the biological clock. In in
vitro studies, serotonin advances the phase of the circa-
dian pacemaker during the day and delays it at night, an
action similar to that of GABA [134]. Serotonin is also
found to regulate SCN neurons by both pre- and post syn-
aptic inhibitory mechanisms [135]. 5HT and 5HT ago-
nists are also found to inhibit optic nerve-induced field
potentials in the SCN brain slice preparation, and light-
induced Fos expression and phase shifts of the circadian
rhythm of wheel-running activity [136]. It is also reported
that 5HT antagonists enhance light-induced increases in
the firing rates of SCN neurons [137] and light induced
phase shifts [138]. Many of the above studies point
towards the hypothesis that the serotonergic innervation
of the SCN serves to modulate light-induced glutaminer-
gic input. Considering these facts, there exists a possibility
of the involvement of 5HT in tonic inhibition of the light-
input pathway to the SCN. There is a suggestion that this
serotonergic projection from raphe to the SCN may be the
anatomical substrate for affective disorders to alter human
circadian system/rhythms. This belief is further strength-
ened by the observation that dysfunction of serotonergic
pathways play a role in affective disorders and that these
disorders are frequently treated with agents that alter ser-
otonergic neurotransmission. Further studies about this
pathway are likely to give more information about the
link between disruptions of circadian function and affec-
tive disorders.
GABA
It is now widely accepted that gamma amino butyric acid
(GABA) is an important neurotransmitter of the SCN for
regulating SCN function. Most SCN neurons express the
neurotransmitter GABA and are thus GABAergic [12].
GABA receptors and receptor subunits have been
described by Castel and Morris [139], Naun and co-work-
ers [140], van den Pol [141], Gao and co-workers [142],
and O'Hara and co-workers [143]. In most of the brain
regions, GABA primarily acts through interaction with
GABAA and GABAB receptors and produces neuronal inhi-
bition through membrane hyperpolarization and
increased membrane conductance. Glutamic acid decar-
boxylase (GAD) is the enzyme required for synthesizing
GABA and is found in nearly all neurons of the SCN [116].
Additional support for an inhibitory role of GABA in the
rat SCN has come from the studies of Gribkoff and co-
workers [144,145]. However, recent investigations have
shown that GABA has dual effects on the SCN neurons,
excitatory during day and inhibitory at night [146], and
this has been attributed to changes in [Cl- ]I during the cir-
cadian cycle. This dual inhibitory [147] and excitatory
[148] action of GABA has been thought of as the probable
reason for the synchronization of spiking in the SCN neu-
rons. Under some circumstances, such as in early develop-
ment, GABA can also be depolarizing and potentially
excitatory [126,149-151]. The excitatory effect of GABA
on SCN neurons in the night seems to be complex. While
the action of GABA in the day on SCN neurons is uni-
formly inhibitory, the effects of GABA during the night are
heterogeneous due to both depolarizing and hyperpolar-
izing effects. The GABA-mediated depolarizing effect seen
at night is restricted to a subset of SCN neurons. Differen-
tial day-night modulation of GABAergic neurotransmis-
sion seen in the SCN may provide a time-dependent
gating mechanism to counteract propagation of excitatory
signals throughout the biological clock during the day
and to promote it at night [152]. GABA does not seem to
be synthesized in the SCN in a circadian fashion, but in a
diurnal pattern as per GAD m RNA basis [153,154]. A cir-
cadian rhythm in GABA transmission in the dorsal part of
the mouse SCN, with requirement of VIP for the expres-
sion of this rhythm, is reported by Itri and co-workers
[155]. While considering the action of GABA in the SCN,
whether inhibitory or excitatory, extrinsic GABA sources
such as from IGL [116] and release of GABA from SCN ter-
minals implicated in transmission of light information
should also be looked into to visualize a clearer picture.
GABA receptors and receptor subunits are expressed in the
SCN [116,139,140]. Although no variation in concentra-
tion of GABA in the SCN has been reported, responsive-
ness of the SCN undergoes daily variation [156].
Neurotransmitters for intra-SCN 
communication
Integrated output as a result of integrated activity within
the SCN in spite of heterogeneity in functional and neuro-
chemical organization explains the efficiency of the SCN,
the biological clock. Such a process is likely to involve
much coordinated activity, and intra-SCN communica-
tion must be strong enough to produce such an action. It
is clear that photic information received must be relayed
from retinorecipient cells to the oscillator cells in the
nucleus. Intra-SCN signals underlying such communica-
tion are not known with certainty as yet. The importance
of circadian synchrony of the SCN neurons in the normal
working of the clock has been highlighted in some animal
studies recently [157]. In these studies, loss of coherent
daily rhythms has been shown to coincide with loss of cir-
cadian synchrony among the constituent neurons [157].
Neurotransmitters have been designated as potential SCN
synchronizers and one of them, which is unique since it isJournal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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expressed by most of the SCN neurons, is GABA. This and
other transmitters involved in synchronization, such as
VIP, GRP and prokineticin 2, have been studied quite
extensively. However, the potential of the latter two, GRP
and prokineticin 2 as synchronizing factors require fur-
ther investigation [23]. Further, it is reported that neuro-
transmitters released by neurons of the ventral part of the
SCN is necessary for maintaining synchrony of the whole
SCN [23 ].
Vasoactive intestinal polypeptide (VIP)
VIP, a gut polypeptide, has been identified as one of the
main neurotransmitters of SCN neurons and participates
in SCN function. These SCN neurons are retinorecipient
and are found in the core of the SCN. They are activated
by light, and exogenous application of VIP can reset the
circadian clock in a manner similar to that of light appli-
cation, both in vitro and in vivo[6]. It is estimated that
9%–24 % of SCN neurons express VIP [26,158]. It appears
that in rats there are two types of VIP neuronal compo-
nents[159], namely a medial GRP-free group and a lateral
group containing GRP. Only the lateral group expresses
per1 following a light pulse [159]. However, few VIP-con-
taining cells rhythmically express per1 and per2 [160,161].
VIP is synthesized from prepro VIP and further cleavage of
the molecule forms VIP and peptide histidine isoleucine
(PHI). PHI is found in abundance in the SCN and is co-
localized [162,163]. VIP and PHI are structurally related
to PACAP. The receptor for VIP, VPAC2,also known as
Vipr2, is expressed in about 60% of the SCN neurons,
which respond to VIP with changes in firing rate
[164,165]. VIP acting through VPAC2 can participate in
both resetting by light and maintenance of ongoing rhyth-
micity in the SCN [6].
VIP along with GRP and AVP show circadian variation in
the level of mRNA in constant environmental conditions
[166]. Some earlier studies [167-169] had indicated that
VIP and GRP do not show circadian rhythms in DD and
only daily rhythms in LD. On the basis of their study, Shi-
nohara et al [168] suggested that changes in the peptide
content by light conditions might reflect changes in the
synthesis and release of peptides. The release of these pep-
tides also shows circadian variation [170]. It has been
reported that treatment of SCN slices with VIP produces
phase shifts similar to those induced by light pulses [171].
Nielsen and co-workers [172] showed that VIP induces
per1  and  per2  gene expression in rat SCN in a phase
dependent manner. More recently, VIP has been shown to
be necessary for the coordination of the daily rhythms in
behaviour and physiology at the level of biological clock
in mice [173]. Loss of internal desynchronization and its
subsequent restoration were achieved by adding VIP into
the mice cells. Thus, VIP signalling through its receptor
serves two important functions in the SCN, namely, circa-
dian rhythmicity in a subset of neurons and maintenance
of synchrony between intrinsically rhythmic neurons.
This may also mean that VIP-expressing neurons them-
selves are circadian pacemakers in the SCN for establish-
ing and synchronizing rhythmic activity.
Vasopressin (AVP)
AVP neurons occupy a large part of the SCN, mostly in the
dorsomedial part of the SCN and are extensively intercon-
nected [174,175], indicating the capacity of the SCN to
produce an integrated output. It is estimated that nearly
one third of the SCN neurons in rats synthesize AVP. It is
one of the major neuropeptides identified in the SCN
[16,176,177]. AVP is synthesized and secreted by the SCN
in a circadian pattern. AVP has an important excitatory
role by activating V1a receptors [177] to increase the
amplitude of firing rates in the SCN during subjective day
[178,179] and enhance SCN output [176,177]. Although
the presence of AVP at the level of the SCN may not be
critical for the expression of some of the circadian
rhythms, abnormalities can be seen in some of the
expressed rhythms in its absence. AVP-deficient Brattle-
boro rats have served as an excellent model for the dem-
onstration of the absence of AVP and subsequent
disturbances in many of the circadian rhythms. Local
application of AVP into the SCN does not affect the free
running circadian wheel running rhythm in ham-
sters[180] or entrained circadian food intake [181] and
water intake [182]. A convincing supportive role for vaso-
pressin in SCN circadian function has come from trans-
plantation studies of DeCoursey and Buggy [183] as well
as that of Lehman and co-workers [184]. Infusion of V1
receptor antagonist has been reported [185] to produce
no significant effect on the wheel running activity in rats,
thereby indicating no role for VP in the generation of cir-
cadian rhythms. Boer and co-workers [186] reported that
vasopressin may not be a critical component in the main-
tenance or in the transfer of circadian activity of the bio-
logical clock for drinking activity based on their graft
transplant study. In depressed patients, both synthesis
and release of AVP in the SCN is reduced, which leads to
an impaired functional activity of the circadian clock
[187], although there was an increase in the number of
AVP-immunoreactive neurons. Arima and co-workers
[188] reported AVP transcription in the SCN in long-term
organotypic cultures. Transcription exhibits circadian
rhythmicity and is dependent on the ongoing electrical
and synaptic transmission in the cultures.
It was mentioned earlier that the predominant excitatory
actions of AVP within the SCN are mediated by V1 recep-
tors, although it is not yet known with certainty whether
V1a or V1b subtypes are involved in the action. Decrease
in the AVP neurons and AVP content in the SCN has been
reported [189-191], and this has been correlated withJournal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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decreased amplitude of activity rhythms, increased
rhythm fragmentation, and disruption of the normal
sleep/wake cycle. However, Hochstetler and co-workers
[192] did not find a correlation between differences in
activity level and circadian expression and differences in
the number of AVP-immunoreactive cells in the SCN. In a
study by Kalamatianos and co-workers [193], it was
reported that there is a decrease in the amplitude of the
daily rhythm in the expression of V1a receptor mRNA
along with persistently elevated level for V1b mRNA in
aged male rats as compared to young adult ones. A role for
AVP in the SCN not only in circadian timing but also in
the circadian memory of radical events has been reported
by Biemans and co-workers [194]. There have been many
attempts in the past to link AVP in the SCN to specific
clock function. However, the attempts have not yielded
definite results so far. Reduction of AVP neurons of the
SCN has been reported to eliminate or reduce the ampli-
tude of many rhythms studied. But at the same time stud-
ies in Brattleboro rats have shown that AVP may not be
necessary to maintain coherent circadian rhythmicity
[195,196]. In house mice, Hochstetler and co-workers
[192] reported that there is no relationship between AVP
neurons in the SCN and circadian features of wheel run-
ning activity. In addition, the SCN also participates in the
communication with the rest of the brain. One such out-
put signal, primarily electrical but not exclusively, is AVP
[197]. Correlation between SCN-AVP expression and cir-
cadian organization of locomotor behaviour has been
shown across species including rats [198] and ham-
sters[199]. However, transplantation studies indicate
some other diffusible factor other than AVP in the regula-
tion of circadian rhythmicity [186].
Melatonin
Melatonin, the hormone from the pineal gland, called the
"darkness hormone " is of great importance in the func-
tioning of the SCN. The most important target of mela-
tonin in humans appears to be the SCN, as the SCN
contains the highest density for melatonin receptors
[200]. A double effect of melatonin in the SCN, namely,
an immediate effect and long term effect, has encouraged
its worldwide use against the ill effects of jet lag. As an
immediate effect, melatonin is found to suppress neuro-
nal SCN activity towards night time levels [201]. It also
lowers VP secretion from SCN neurons as shown by exper-
iments in rats [202]. Acceleration of sleep initiation in
humans at circadian phases when the SCN would nor-
mally stimulate waking is another reported action of
melatonin [203]. In terms of long term effect, melatonin
can phase shift and amplify circadian rhythmicity of the
SCN. Melatonin application has been found to be useful
in synchronizing the endogenous circadian rhythms not
only in people who suffer from jet lag, but also in blind
individuals [204,205], patients with dementia [206], and
shift workers [207]. Probably recognizing the importance
of melatonin as a chronobiotic, many researchers have
studied the applications of melatonin on human circa-
dian rhythms. Recently, Revell and co-workers reported
that administration of a combination of morning inter-
mittent bright light and afternoon melatonin along with a
gradually advancing sleep schedule can advance circadian
rhythms almost an hour a day, with very little circadian
misalignment [208]. This protocol might be applied
before eastward jet travel or for delayed sleep phase syn-
drome to evoke a phase advance of the circadian clock
[208]. In spite of the experimental evidence favouring a
very important role for melatonin in the circadian timing
system, the exact role of melatonin has not been demon-
strated clearly. Melatonin and seasonal rhythms are inti-
mately related in mammals, and this has been well
documented [209,210]. Lincoln and co-workers [211]
provided evidence for a temporal melatonin-controlled
expression of clock genes in specific calendar cells. The
retinohypothalamic -pineal (RHP) axis is comparable in
animals and humans. In both animals and humans mela-
tonin is secreted exclusively at night. The RHP is capable
of detecting changes in night length to make proper
adjustments for the duration of nocturnal melatonin
secretion so that animals can use this melatonin message
to trigger seasonal changes in behaviour [209]. With sea-
sonal changes in night duration, there are parallel changes
in the duration of melatonin secretion, and this leads to
more secretion as compared to summer.
Neurotransmitters in efferent projections
The output of the SCN by way of efferent projections
serves the purpose of conveying the information to the
related centres. Outputs are primarily seen to the nearby
hypothalamic and thalamic nuclei from the SCN, particu-
larly to the medial preoptic nucleus, the medial part of the
paraventricular nucleus of the hypothalamus, the anterior
part of the paraventricular nucleus of thalamus, the
medial part of the dorsomedial nucleus of hypothalamus,
and principally the subparaventricular zone [212,213].
Projections to the ventrolateral preoptic nucleus from the
dorsomedial nucleus, the preoptic nucleus and the sub-
paraventricular zone appear to serve as the anatomical
basis for the control of sleep and wakefulness, as the ven-
trolateral preoptic nucleus is implicated in the control of
sleep states [214-216]. Efferent projections seem to have
mainly AVP and VIP as transmitters. These fibres that orig-
inate in the SCN can be seen for long distances within the
hypothalamus and have a characteristic morphology. The
functional significance of these projections remains to be
fully determined, apart from the basic fact that they are
necessary for the SCN to exert its overt function. The func-
tional role has been described to some extent earlier
[217].Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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Although the SCN is often designated as the "master" cir-
cadian pacemaker that drives most, if not all, rhythmic
physiological processes, the importance of oscillators out-
side the SCN cannot be ignored. Indeed, there is consider-
able evidence for the existence of circadian pacemakers
outside the SCN [218-220] (Figure 2). It is believed that
the master circadian pacemaker (the SCN) has peripheral
"slave" oscillators that may be individual clocks. It is nec-
essary in such a situation to have a mechanism by which
peripheral oscillators are coupled to the master oscillator
thereby synchronizing the activity of an organ with the
central clock. A humoral substance mediating the circa-
dian signal may be available in the efferent output in such
case [221]. One such recently identified diffusible output
candidate from the SCN is transforming growth factor α
(TGFα) [222]. TGFα is found extensively in the brain and
is a member of the epidermal growth factor (EGF) family
produced by both neurons and astrocytes [223]. In situ
hybridization and immunocytochemistry techniques
have demonstrated the presence of TGFα in the SCN of
rats [224,225] and Syrian hamsters [222,226,227]. Van
der Zee and co-workers [228] reported that the two output
systems of the SCN, namely AVP and TGFα, are anatomi-
cally separate, having different daily profiles in expres-
sion.
SCN output pathways in addition to influencing the
hypothalamic neighbourhood [229] can be traced to extra
hypothalamic sites as far as the liver, thyroid, adrenal, and
salivary glands in rats [230,231]. Both neural output path-
ways and diffusible non-neural pathways become impor-
tant in elucidating the functional significance of SCN
output in terms of the control of the SCN on other oscil-
lators.
Though the various mechanisms used to regulate the
activity of other systems of the body is unclear at present,
a number of hormones with direct actions on different
parts of the body are produced by the SCN. These include
AVP, VIP, GRP, and SS. A review by Van Esseveldt and co-
workers [9] describes not only the transmitters of RHT but
also the output of the SCN. A long neural signalling path-
way from the SCN regulates the pineal gland secretion of
melatonin. SCN neurons also stimulate gonadotrophin
releasing hormone (GnRH) synthesizing neurons of the
preoptic area and thereby affect sex hormone cycles [232].
It is generally seen that outputs of the circadian system are
rhythmic but not temperature compensated. In spite of
the difficulties to understand the mechanisms by which
the SCN regulates a wide range of physiological outputs,
it has been agreed that there are two types of signals orig-
inating from the SCN. These are hormonal and neural
outputs. Transplantation experiments [233] in particular
have provided highly useful evidences for the suggestion
that hormonal /diffusible factors produced by the SCN act
as an important output signal for the circadian system
[234]. Quick recovery of behavioural rhythms within 4
days of transplantation of the SCN [184], successful place-
ment of transplants at locations distant from the SCN
[184], and transplanted dissociated SCN cells capable of
restoring rhythmicity [235] are all in favour of hormonal
/diffusible factors as the output signal.
It is possible that different physiological systems are con-
trolled by either neural or hormonal output from the
SCN. For example, rhythmic secretion of melatonin could
be under neural control while locomotor activity might be
under hormonal control. Also, a specific physiological
function may receive both neural and hormonal signals.
As regards to the communication of information from the
circadian clock to the centres controlling activity in brain
areas, more than one mode is indicated [222,236].
Analysis of the chemoarchitecture of the SCN have shown
that, in addition to the above neurotransmitters, the SCN
also contain neurons capable of synthesizing a number of
other neurochemicals, with the distribution of immuno-
reactive neurons differing slightly for each neurochemical.
A few of these neurochemicals are described here.
Somatostatin (SS)
SS producing neurons of the SCN are located in both the
core and shell portions [237] and form a distinct peptider-
Inter-relation and efferent outputs between central and  peripheral oscillators Figure 2
Inter-relation and efferent outputs between central 
and peripheral oscillators. Notice the neural and diffusi-
ble control of the central oscillator. Peripheral oscillators 
respond to signals from SCN as well as to other inputs like 
periodic food availability. Diffusible output may have AVP, 
VIP, prokineticin, and TGF-α. RHT: Retinohypothalamic 
tract, dm: dorsomedial SCN, vl: ventrolateral SCN.Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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gic neuronal group. These cells are few in the mouse SCN,
but are large in size. Part of the SS and Substance P (SP)
peptides are co-localized [238]. The shell portion of the
SCN, which is likely to be involved in the regulation of
overt rhythms, projects within the SCN through SS fibres
[239]. In an interesting study, Biemans co-workers [240]
reported a significant increase in SS and SP immunoreac-
tivity in aged Wistar rats as compared to young ones,
thereby indicating that not all SCN neuropeptidergic sys-
tems decline with age. However, another study in Syrian
hamsters [241] showed that there is no effect of age on SS
mRNA. Aging effects of SCN neuropeptide expression, like
the circadian profile of peptide expression, may be species
specific as far as the SCN is concerned. Further, it has been
reported [242] that SS has a role in phase shifting and is
able to reset the phase of the clock [243]. Synapse of SS
fibres on VIP and AVP neurons and presence of SS recep-
tors in the SCN is suggestive of a regulatory role for SS on
other peptidergic neurons. An inhibitory modulating role
of SS on VIP rhythmicity is seen [244]. Increase in SS
immunoreactivity could explain the observed VIP
decrease with aging, and, if enhanced SS immunoreactiv-
ity reflects a release deficit, this may lead to reduction in
inhibitory action [240].
Calbindin (CalB)
Calbindin (CalB) neurons are also found throughout the
core and shell subdivisions of the SCN. Silver and co-
workers [245] reported the presence of CalB-containing
cells in the caudal part of the SCN. CalB cells are densely
packed and receive direct retinal synaptic input [246] and
respond to photic stimuli. Study of Silver and co-workers
[245] indicates that CalB cells are present in the input
pathway for photic stimuli reaching the SCN. The CalB
subregion of the SCN seems essential for the maintenance
of circadian locomotor activity rhythm. This comes from
the studies of lesion as well as transplantation. Animals
with lesions that destroyed CalB neurons but spared other
neurons of the SCN lost rhythmicity of locomotor activity,
and transplants of SCN tissue containing CalB cells
restored rhythmicity. SCN transplants lacking CalB cells
failed to restore rhythmicity [247]. CalB cells are found to
co-localize with other peptides such as GRP, SP, and VIP.
Interconnections of CalB cells with AVP, GRP, CCK, NPY
and VIP have been reported [246], and the pattern of
interconnection of CalB cells appear specialized in the
sense that some are bilateral, while others are not [248].
The strength of linkage between interconnections also var-
ies. Intra-SCN connections are influenced to a great extent
by the projections of CalB cells. The connections are direct
in some cases and indirect in others. However, indirect
communication as is the case with CalB to AVP is equally
effective. In addition to intra SCN communication, CalB
cells may also project to extra SCN regions [248]. CalB
cells appear to be non rhythmic. They, however, receive
photic input from the RHT and GHT, and rapid transmis-
sion of light information to CalB neurons may facilitate
circadian output [226]. Light exposure always increases
firing rates of SCN neurons. However, cells in the core of
the SCN oscillate in their responsiveness to photic input
[5]. Light also induces clock gene expression in the SCN
but only during the night [8,249]. This gene expression
pattern seems to be mirrored by changes in subcellular
localization of CalB, the cellular nucleus being devoid of
CalB during the night [249]. Behavioural and molecular
responses to nocturnal light pulses also disappeared on
decreasing CalB levels [249]. Thus, CalB cells in the SCN
function as gates to relay photic signals when open and to
block the signals when closed, which suggests a central
role for CalB neurons in gating photic input. Further
investigation seems essential to elucidate the relation
between functional connectivity and a single coherent
output from the SCN.
Calretinin (CALR)
Calretinin (CALR) is another variety of neurons found in
the SCN (in the core ventral part) that appears to be co-
localized with VIP neurons. CALR cells are small to
medium sized. Optic tracts also show heavy immunoreac-
tivity for CALR. Like calbindin (CalB), CALR is a calcium
binding protein. Apparently, there is a developmental
reduction in Calbindin-D28k expression parallel to RHT
formation and a developmental increase in calretinin
expression which is independent of RHT connections to
SCN neurons [250].
Galanin (Gal)
Galanin is yet another peptide associated with the SCN. It
is a 29/30 amino acid neuropeptide seen in many parts of
the nervous system [251], including the SCN [9,252,253].
In fact, neurons containing both galanin and AVP have
been reported in human SCN [253]. In rat SCN, galanin
receptor subtype R2 (Gal-R2) expression has been identi-
fied [254].
Angiotensin II (ANG II)
Angiotensin II (ANG II) is an octapeptide found in the
SCN [15,255] and is likely to be involved in circadian
function. The presence of ANG II in the SCN has been
demonstrated both at light microscopic [15] and electron
microscopic level [256] in normotensive rats. Of late there
has been much interest in the physiological, pharmaco-
logical, and immunohistological studies of angiotensins
of the SCN. At present the available information on the
role of angiotensin II at the level of the SCN is much less
than that on the role of known transmitters of the SCN. It
has been proposed that SCN-derived angiotensin II acts as
a neuromodulator as well as neurotransmitter with the
effects being mediated through angiotensin1(AT1) recep-Journal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
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tors located on the endothelial plasma membrane of SCN
parenchyma [257].
Met-Enkephalin (mENK)
These neurons are located primarily dorsomedially in the
shell of the SCN and overlap with the distribution of AVP
neurons. mENK cells are large to medium sized. Enkepha-
lin has been found in the neurons of the IGL
[116,117,122,258] projecting to the ventrolateral aspect
of the SCN. The role of enkephalin as a putative neuro-
transmitter has been demonstrated in hamster SCN. Injec-
tion of retrograde tracer fluoro-gold into the SCN showed
the existence of a population of labelled neurons in the
intergeniculate leaflet which are immunoreactive for
enkephalin [117]. Among the three main classes of opioid
receptors, little δ or µ opioid receptor expression has been
identified through autoradiographic techniques in ham-
ster SCN in vitro [259,260]. No direct effect on basal or N-
methyl-D-aspartate (NMDA)-evoked firing rates of SCN
neurons in hamster has been observed on short -term
application of opioid receptor agonists [261]. However,
the observation of SCN neurons exhibiting withdrawal
responses after the influence of enkephalins had been
removed indicates that endogenous opioids may play a
role in modulation of SCN function. On the other hand,
naloxone injection into the SCN is reported to produce
disruption of the circadian pattern of food [262] and
water [263] intake.
Prokineticin 2 (PK2)
Prokineticin 2 (PK2) has been identified as an output
molecule from the SCN circadian clock [236]. PK2 is a
cystein-rich secreted protein. It is reported to be involved
in the transmission of behavioural circadian rhythm as
well as in local function within the SCN to synchronize
the out put [236]. PK2, named for its ability to stimulate
intestinal smooth muscle contractility, is proposed to
have a major role in inhibiting locomotor activity during
the day in nocturnal species [236]. Receptors for PK2,
PKR2, are found abundantly in the target nuclei of the
SCN output pathway, indicating again that it is an output
molecule. A recent study [264] demonstrated that the
molecular rhythm of PK2 in the SCN is regulated by both
circadian clock and light, with the clock having a predom-
inant role and light having a modulatory role. PK2 expres-
sion induced by light independent of the circadian
oscillator may also indicate participation of PK2 in the
photic entrainment of circadian rhythms. Evidence sug-
gesting diurnality in behavioural patterns based on altera-
tions in PK2 receptors in regions receiving SCN efferents
does not seems to provide a complete answer at least in
rodents[265]. The action may be downstream of the SCN
or may be in parallel to the PK2/PKR2 receptor sys-
tems[265].
Relationship between the biological clock of 
humans and those of other mammals
The majority of studies of SCN function has been con-
ducted on laboratory animals, particularly the rat. Similar-
ities in the anatomical and physiological data available
strongly suggest that the SCN of humans and other mam-
mals are functionally similar. Two unique case reports
[266,267] suggested that lesions of the SCN lead to dis-
ruption of circadian rhythmicity in humans. The location
of the SCN, in the anterior hypothalamus, bilaterally next
to third ventricle and above the optic chiasm, and the
afferent and efferent projections of the SCN are similar in
humans and other mammals. In the case of neurotrans-
mitters involved in SCN function, also similar number
and well defined subdivisions can be seen. Human SCN
additionally contain neurotensin as a neurotransmitter.
In general, human SCN has well defined subdivisions
with chemically defined neuronal groups comparable to
those described in experimental animals [18]. More
details can be seen in the review article by Scheer and co-
workers [268]. A recent review by Bell-Pedersen and co-
workers [269] summarizes the similarities and differences
in different organisms and discusses the organization of
the circadian system as a composite of multiple oscilla-
tors. The endogenous nature of the clock, its entrainment
by time cues, its phase response curves for light and mela-
tonin, and its electrophysiological and metabolic activity
are other features that are common to humans and other
mammals.
Studies on animal models have helped the understanding
of many disease conditions seen in humans. The lack of
proper functioning of the biological clock seen in the eld-
erly, the ill effects of jet lag, and clinical intolerance in
shift workers are all topics of current research in experi-
mental studies. Animal experimentation with new rodent
models for circadian study involving transgenic and
knockout mice and rats have contributed to our under-
standing of the above as well as many other conditions. Fu
and collaborators [270] showed that the life span of their
period2 knockout mice was less than that of wild type sib-
ling mice. They also reported that these mice develop
spontaneous lymphomas of high frequency, which sug-
gests that the period2  gene plays an important role in
tumor suppression. Studies on liver regeneration after par-
tial hepatectomy in mice showed that regeneration occurs
only at certain times of the circadian day [271]. A clear
mechanistic link between the clock and tolerance to anti-
cancer drugs has been reported [272].
Genes and their linkage with neurotransmitters in the 
working of the clock
Presence of robust, overt circadian rhythm expression by
the SCN depends on a stable pacemaker with period
length of approximately 24 hours. This in turn is madeJournal of Circadian Rhythms 2006, 4:2 http://www.jcircadianrhythms.com/content/4/1/2
Page 13 of 20
(page number not for citation purposes)
possible by the integration of the thousands of individual
cellular clocks found in the SCN. Using real-time analysis
of gene expression, Yamaguchi and co-workers [30] have
shown synchronized rhythms of clock gene transcription
across hundreds of neurons within the mammalian SCN.
Whether it is the neurotransmitters in the afferent input to
the SCN, or of the SCN itself or efferent projection from
the SCN, neurotransmitters and their linkage with genes
are important, and this has been the basis for the informa-
tion now available on the molecular basis of the biologi-
cal clock and its working.
In mammals, the molecular mechanism for generation of
circadian rhythms is dependent on the concerted co-
expression of specific clock genes [273]. The genes in
mammals are the period (per1, per2, and per3), crypto-
chrome (cry1  and  cry2), clock (clk), and brain-muscle-
Arnt-like-protein 1 (bmal1) genes. It is now known that
light entrainment of the clock involves the induction of c-
Fos [274] and clock genes per1 and per2 [275-277]. These
genes are rapidly induced in the SCN by light stimulation
at those time points at which light phase shifts the clock.
Possible genes for glutamate and PACAP thus appear to be
the clock genes per1 and per2, which are induced in the
SCN by light, glutamate and PACAP at night. Further,
Nielsen and co-workers [172] also have shown that VIP
induces per1 and per2 expression in a phase-dependent
manner, thereby suggesting that VIP is important for the
light-induced phase shift at night.
Neurotransmitters and disease conditions
Researchers have started to identify the role of the SCN in
certain disease conditions. SCN dysfunction, particularly
in terms of neurotransmitter content, has been associated
with several chronic diseases such as hypertension, diabe-
tes, and depression [278,279].The anatomical picture
with respect to staining in the SCN is changed in sponta-
neous hypertensive rats (SHR), and transplantation of
hypothalamic tissue containing the SCN from SHR to nor-
motensive rats induces hypertension [280]. Decrease in
staining for many SCN neurotransmitters along with an
enhanced activity of paraventricular nucleus (PVN) CRH
neurons have been observed in hypertensive patients
[281]. This suggests that, in humans, the SCN may have
an inhibitory role in the CRH neurons of the PVN. These
observations strongly suggest that a changed SCN may
precede the development of hypertension. There is also
evidence that circadian disturbances may be detected
prior to the development of diabetes or hypertension
[282,283]. Further evidence that the functionality of the
biological clock may be affected in humans by diseases
such as depression and hypertension has been provided
by post-mortem analysis of the SCN in human physiolog-
ical disorders by Zhou and co-workers [187] and Gon-
charuk and co-workers [280]. One of the possible
explanations for the development of hypertension may be
that a less active SCN may prepare an individual less effec-
tively for the new period of activity, and that repetition of
this strain over the years may result in hypertension. One
can find support for this theory in the observation that
cardiovascular accidents precipitate during morning
hours when the onset of activity occurs.
Conclusion
Neurotransmitters of the circadian clock have been inves-
tigated more and more with the unfolding of the under-
standing of the clock, particularly at the molecular level.
From a time when hardly anything was known about neu-
rotransmitter involvement in the working of the clock, we
have come to a stage of controlled manipulation on the
basis of the properties and nature of neurotransmitters.
The ill effects of jet lag, clinical intolerance to shift work,
disruptions of the working of the clock with old age and
their correction to some extent with the help of chemicals,
especially those like melatonin, will hopefully be treated
in the near future by interventions developed with knowl-
edge of SCN neurotransmitters. Chronotherapy has
become an advantageous therapeutic option for many dis-
ease conditions. Chronomodulation methods for chemo-
therapy, radiotherapy and even immunotherapy have
been highlighted by many researchers and physicians in
the recent past for treatment of patients with cancer. With
the advances in molecular chronobiology and clarifica-
tion of its mechanisms, chronotherapy is likely to become
increasingly accepted as a effective means for treating not
only cancer but also many other disease conditions. Thus,
knowledge of the workings of the clock and its neuro-
transmitters appears to be essential not only for disease
prevention but for therapeutic practice as well.
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